Pendrea Bio, Inc.
PrivateLast Round
Grant
Sep 1, 2015
Total Funding Raised
$5.88M
Company Overview
Pendrea Bio, Inc. is a biotechnology company that develops nanoscale drug delivery vehicles for diagnosing and treating human diseases, particularly cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pendrea Bio, Inc. Comps
Public and private peers based on sector, stage, and business model.
Pendrea Bio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 1, 2015 | ||||
| Seed | Oct 1, 2008 |
Pendrea Bio, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Ben Franklin Technology Partners of Central & Northern PA | Seed |
| NIH RADx | Grant |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2015
$2M grant round led by National Cancer Institute.
- Oct 1, 2008
$3M round led by Ben Franklin Technology Partners.
Pendrea Bio, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Pendrea Bio, Inc.'s valuation, stock price, and market status.
